MyImmune
Biotechnology Research • 
Wilmington, Delaware, United States • 1-10 Employees
Company overview
| Headquarters | 251 Little Falls Drive, Wilmington, Delaware 19808, US |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Diagnostics, AI, Immunology, Patient Stratification, Repertoire |
| Founded | 2024 |
| Employees | 1-10 |
Key Contacts at MyImmune
Ayan Sengupta
Co-Founder & Cto
Daron Standley
Co-Founder And Chief Scientific Advisor
About MyImmune
MyImmune is developing an AI-powered platform that unlocks the full potential of the human immune system to understand, detect, and treat disease. Our technology delivers unprecedented insight into immune responses, enabling earlier diagnosis and better therapies for underserved conditions like cancer, autoimmune, and neurodegenerative diseases.
$
MyImmune revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Entry
C-Suite
Founder/Owner
Employees by Department
MyImmune has 6 employees across 4 departments.
Departments
Number of employees
Funding Data
MyImmune has never raised funding before.
Norway
Germany
Belgium
Frequently asked questions
MyImmune is located in Wilmington, Delaware, US.
MyImmune was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
MyImmune has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
